Cosfroviximab
Cosfroviximab (c13C6-FR1) is a mouse/human chimeric monoclonal antibody against Ebola virus glycoprotein (EBOV-GP) [1].
Product Specifications
CAS Number
1792982-57-0
Product Name Alternative
C13C6-FR1
UNSPSC
12352203
Target
Filovirus
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cosfroviximab.html
Purity
95.00
Solubility
10 mM in DMSO
Smiles
[Cosfroviximab]
Molecular Weight
(145.34 kDa)
References & Citations
[1]Carly Fleagle Chisholm, et al. Thermostable Ebola virus vaccine formulations lyophilized in the presence of aluminum hydroxide. Eur J Pharm Biopharm. 2019 Mar;136:213-220.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
EBOV
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
